| Q33230192 | 3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. |
| Q28473002 | A computational approach for deciphering the organization of glycosaminoglycans |
| Q44816865 | A new model for the domain structure of heparan sulfate based on the novel specificity of K5 lyase. |
| Q30386218 | A synergistic approach to protein crystallization: combination of a fixed-arm carrier with surface entropy reduction. |
| Q37216313 | Biological implications of glycosaminoglycan interactions with haemopoietic cytokines. |
| Q31074211 | Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding |
| Q63362963 | Characterization and Quantification of Highly Sulfated Glycosaminoglycan Isomers by Gated-Trapped Ion Mobility Spectrometry Negative Electron Transfer Dissociation MS/MS |
| Q33285352 | Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. |
| Q33806757 | Chemoenzymatic synthesis and structural characterization of 2-O-sulfated glucuronic acid-containing heparan sulfate hexasaccharides |
| Q47265732 | Chondroitin sulfate chains on syndecan-1 and syndecan-4 from normal murine mammary gland epithelial cells are structurally and functionally distinct and cooperate with heparan sulfate chains to bind growth factors. A novel function to control bindin |
| Q33480621 | Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes |
| Q42820482 | Covalently attached FGF-2 to three-dimensional polyamide nanofibrillar surfaces demonstrates enhanced biological stability and activity |
| Q51556332 | Deciphering functional glycosaminoglycan motifs in development. |
| Q33222215 | Demonstration of the pleiotrophin-binding oligosaccharide sequences isolated from chondroitin sulfate/dermatan sulfate hybrid chains of embryonic pig brains |
| Q37256534 | Differential sulfation remodelling of heparan sulfate by extracellular 6-O-sulfatases regulates fibroblast growth factor-induced boundary formation by glial cells: implications for glial cell transplantation. |
| Q36332838 | Endothelial heparan sulfate 6-O-sulfation levels regulate angiogenic responses of endothelial cells to fibroblast growth factor 2 and vascular endothelial growth factor. |
| Q90158049 | Evaluation of top-down mass spectrometry and ion-mobility spectroscopy as a means of mapping protein-binding motifs within heparin chains |
| Q33897755 | Extended N-sulfated domains reside at the nonreducing end of heparan sulfate chains. |
| Q33282863 | Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells |
| Q35082690 | FGF2 binding, signaling, and angiogenesis are modulated by heparanase in metastatic melanoma cells |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q58377532 | Fibroblast Growth Factor Receptors 1 and 2 Interact Differently with Heparin/Heparan Sulfate |
| Q31153852 | Fibroblast growth factors share binding sites in heparan sulphate |
| Q36923642 | Fibroblast growth factors, old kids on the new block |
| Q47148090 | Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study |
| Q33551154 | Generating heparan sulfate saccharide libraries for glycomics applications. |
| Q24541580 | HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. |
| Q35219652 | Heparan sulfate 2-O-sulfotransferase (Hs2st) and mouse development. |
| Q26796383 | Heparan sulfate and heparin interactions with proteins |
| Q38050077 | Heparan sulfate biosynthesis: regulation and variability |
| Q33615579 | Heparan sulfate domain organization and sulfation modulate FGF-induced cell signaling |
| Q42276329 | Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities |
| Q35059448 | Heparan sulfate proteoglycans |
| Q38747421 | Heparan sulfate proteoglycans as key regulators of the mesenchymal niche of hematopoietic stem cells. |
| Q35780214 | Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma |
| Q38311931 | Heparan sulfate-related oligosaccharides in ternary complex formation with fibroblast growth factors 1 and 2 and their receptors |
| Q34328757 | Heparan sulfate: growth control with a restricted sequence menu |
| Q54888139 | Heparan sulphate proteoglycans in glia and in the normal and injured CNS: expression of sulphotransferases and changes in sulphation |
| Q41504553 | Heparanase Inhibitors Facilitate the Assembly of the Basement Membrane in Artificial Skin |
| Q47159791 | Heparin Mimetics: Their Therapeutic Potential. |
| Q44120939 | Heparin inhibits DNA synthesis and gene expression in alveolar type II cells |
| Q39111023 | Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR. |
| Q37736668 | Heparin-derived heparan sulfate mimics to modulate heparan sulfate-protein interaction in inflammation and cancer |
| Q92152542 | Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers |
| Q28213553 | Hereditary multiple exostoses and heparan sulfate polymerization |
| Q33864454 | Highly sulfated nonreducing end-derived heparan sulfate domains bind fibroblast growth factor-2 with high affinity and are enriched in biologically active fractions |
| Q39984528 | Hydrogen peroxide as a potential mediator of the transcriptional regulation of heparan sulphate biosynthesis in keratinocytes |
| Q36194268 | Inactivation of heparan sulfate 2-O-sulfotransferase accentuates neutrophil infiltration during acute inflammation in mice. |
| Q42491092 | Influence of heparan sulfate chains in proteoglycan at the dermal-epidermal junction on epidermal homeostasis |
| Q33542995 | Interaction of E2 glycoprotein with heparan sulfate is crucial for cellular infection of Sindbis virus |
| Q38312237 | Isolation and characterization of low sulfated heparan sulfate sequences with affinity for lipoprotein lipase |
| Q28278567 | Keratinocyte growth factor/fibroblast growth factor 7, a homeostatic factor with therapeutic potential for epithelial protection and repair |
| Q36964230 | LC-MS and LC-MS/MS studies of incorporation of 34SO3 into glycosaminoglycan chains by sulfotransferases |
| Q35945285 | Long-lived engineering of glycans to direct stem cell fate |
| Q34652072 | Mammalian heparanase: what is the message? |
| Q33819268 | Matrix regulators in neural stem cell functions |
| Q34310374 | Molecular diversity of heparan sulfate |
| Q33676686 | Molecular mechanism of substrate specificity for heparan sulfate 2-O-sulfotransferase |
| Q43197470 | Multimers of the fibroblast growth factor (FGF)-FGF receptor-saccharide complex are formed on long oligomers of heparin. |
| Q36851279 | Multivalent proteoglycan modulation of FGF mitogenic responses in perivascular cells. |
| Q34602695 | Mutational study of heparan sulfate 2-O-sulfotransferase and chondroitin sulfate 2-O-sulfotransferase. |
| Q56833662 | New tools for carbohydrate sulfation analysis: heparan sulfate 2--sulfotransferase (HS2ST) is a target for small-molecule protein kinase inhibitors |
| Q79210669 | Nitrocellulose Filter Binding to Assess Binding of Glycosaminoglycans to Proteins |
| Q46391304 | Novel heparan sulfate structures revealed by monoclonal antibodies |
| Q36071884 | Novel therapeutic targets in the brain tumor microenvironment |
| Q31139063 | Oligosaccharide Library-based Assessment of Heparan Sulfate 6-O-Sulfotransferase Substrate Specificity |
| Q36219228 | Podocyte-specific deletion of NDST1, a key enzyme in the sulfation of heparan sulfate glycosaminoglycans, leads to abnormalities in podocyte organization in vivo |
| Q38181492 | Post-Synthetic Regulation of HS Structure: The Yin and Yang of the Sulfs in Cancer |
| Q42120275 | Precocious initiation of spermatogenesis in a 19-month-old boy with Hurler syndrome |
| Q36182371 | Proteoglycan sequence |
| Q38680940 | Proteoglycans and axon guidance: a new relationship between old partners |
| Q36816444 | Proteoglycans and their roles in brain cancer |
| Q39155470 | Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling |
| Q27652967 | Redirecting the substrate specificity of heparan sulfate 2-O-sulfotransferase by structurally guided mutagenesis |
| Q34361094 | Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function |
| Q34489556 | Role of heparan sulfate in fibroblast growth factor signalling: a structural view |
| Q34989564 | Role of heparan sulfate-2-O-sulfotransferase in the mouse. |
| Q34718195 | Roles of heparan-sulphate glycosaminoglycans in cancer |
| Q36324847 | Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly |
| Q42525353 | Spatiotemporal distribution of heparan sulfate epitopes during myogenesis and synaptogenesis: a study in developing mouse intercostal muscle |
| Q38334596 | Specific structural features of heparan sulfate proteoglycans potentiate neuregulin-1 signaling |
| Q55655141 | Stimulation of wound healing using bioinspired hydrogels with basic fibroblast growth factor (bFGF). |
| Q36822084 | Strategies in synthesis of heparin/heparan sulfate oligosaccharides: 2000-present |
| Q38974435 | Structural alteration of cell surface heparan sulfate through the stimulation of the signaling pathway for heparan sulfate 6-O-sulfotransferase-1 in mouse fibroblast cells. |
| Q40601795 | Structural determinants of heparan sulphate modulation of GDNF signalling |
| Q34805392 | Structural specificity of heparin binding in the fibroblast growth factor family of proteins |
| Q34523315 | Structure and biological interactions of heparin and heparan sulfate |
| Q50875019 | Structure-Activity Relationships of Bioengineered Heparin/Heparan Sulfates Produced in Different Bioreactors. |
| Q24550887 | Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer |
| Q40630770 | Sulfated Derivatives of Escherichia coli K5 Polysaccharides as Modulators of Fibroblast Growth Factor Signaling |
| Q33370024 | Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis |
| Q34943513 | Surface-templated hydrogel patterns prompt matrix-dependent migration of breast cancer cells towards chemokine-secreting cells |
| Q79230764 | Synthesis of heparin-like oligosaccharides on a soluble polymer support |
| Q80866631 | Synthesis of heparin-like oligosaccharides on polymer supports |
| Q38290246 | The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. |
| Q38100660 | The African Fusarium/maize disease |
| Q24306406 | The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans |
| Q34412830 | The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. |
| Q40315779 | The morphogenic properties of oligomeric endostatin are dependent on cell surface heparan sulfate |
| Q34474956 | The specificity of interactions between proteins and sulfated polysaccharides |
| Q44368469 | The structural biology of growth factor receptor activation |
| Q37445949 | Therapeutically targeting protein-glycan interactions |
| Q27028136 | Understanding the substrate specificity of the heparan sulfate sulfotransferases by an integrated biosynthetic and crystallographic approach |